evolocumab
amgen,astellas
['evolocumab', 'fourier']
dr. prakriti gaba presents her work on long-term efficacy of very low ldl-cholesterol levels with the pcsk9 inhibitor evolocumab: analysis of the fourier and fourier-ole studies, tomorrow :16pm ct, main event iii. #aha22 
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.